How are medical device enterprises leveraging EIIR providers? (Deals/Contracts/ Partnerships)
For a leading medical device manufacturer, LTTS is executing a complete DHF and EU Medical Device Regulation & Remediation project in the Newborn Care and Neurology markets. As part of the project, the team will be conducting gap analysis & complete DHF and MDR remediation and certifications for 50+ accessories covering class 1 products.
TCS is selected by a leading medical devices company, to develop a Hyperledger Fabric blockchain solution to track products for sterilization from manufacturing through distribution for efficient process automation and improved movement visibility across stakeholders.
Lonza selects Rockwell Automation for digital transformation of pharmaceutical operations. Lonza to use PharmaSuite MES software, along with FactoryTalk InnovationSuite to accelerate paperless, 24/7 production of cutting-edge capsules.
Critical Manufacturing is awarded a MES contract by Nypro, a Jabil company in medical devices manufacturing. The new MES system will sit between Nypro’s current PLM application and ERP system and will be implemented across 15 plants.
Penumbra has selected Siemens Opcenter Execution Medical Device and Diagnostics (formerly known as Camstar Medical Device Suite). The solution, which enables paperless manufacturing in an FDA-regulated environment, will be the foundation for an operational excellence platform designed to establish a more predictable manufacturing process and supply chain.
How are medical device enterprises organizing their R&D? (GICs/ R&D Best Practices/Solutions)
Scientists at ETH Zurich and the South African company Strait Access Technologies are using 3-D printing to produce custom-made artificial heart valves from silicone. This could help meet an aging population’s growing demand for replacement heart valves.
Siemens Healthineers is dashing deeper into surgical robotics, shelling out $1.1 billion in cash to pick up Corindus Vascular Robotics , maker of a minimally invasive platform for coronary, peripheral and neurovascular procedures.
Sahajanand Medical Technologies (SMT), an India-based manufacturer of Coronary stent systems, has received CE mark for Supraflex Cruz, its next-generation Supraflex stent system. Supraflex Cruz is a Sirolimus-eluting stent built on a cobalt-chromium platform. SMT’s ultra-thin platform with biodegradable polymer is deemed one of the most advanced technologies in the world. SMT’s new Hyderabad plant will be Asia’s largest stent manufacturing facility. The proposed plant will be up and running by 2020 with an investment of Rs 250 crores (some US$35 million). The plant will also have a research and development (R&D) centre. The unit will be manufacturing one million stents and two million balloon catheters per annum.
Sanofi has opened its first Asian R&D center in Chengdu, China. The company will spend 66 million euros ($73.6 million) in the southwestern Chinese city, conducting research on a host of ailments such as diabetes and immunological diseases. Pharmaceutical companies from around the world are setting up research and development hubs in China to take advantage of the reams of data generated by a nation of 1.3 billion people.
The world’s largest virtual hospital is set to be built in Bydgoszcz by InventionMed, a medical technology firm that uses virtual and augmented technology simulators to aid the training of medical professionals. It will also act as a leading edge R&D centre.
Siemens Healthineers is collocating its state of art medical imaging manufacturing unit with its largest R&D center in India. A winning combination.
MicroPort will establish a new services center in Costa Rica in addition to its current R&D operation for orthopedic medical devices. Currently, the company’s operations are mainly focused on designing instruments for total knee replacements using 3D images for each patient. These designs are sent to the company’s facilities in the United States, where they are manufactured using 3D printers and distributed worldwide.
How are medical device providers developing their solutions and capabilities?
ALTEN Calsoft in partnership with Clinlogix launches Blockchain for Clinical Trials
TCS has launched ADD Site Feasibility Platform. The new platform consolidates data currently residing on multiple systems within the enterprise into a central knowledge repository from which it derives insights that can be used to identify the sites best suited for a given study protocol, with the most appropriate patient population and investigators.
Wipro has partnered with Intel. Wipro has launched edge AI solutions for pipeline anomaly detection, surface crack detection and medical anomaly detection all powered by Intel Xeon processors. These solutions are designed to be customizable as per each customer’s specific needs and then integrated into their broad technology environment, thereby accelerating time-to-market and reduction in R&D costs.
HCL and Oracle Health Sciences announced a collaboration to help life sciences companies execute and scale the next generation of digital clinical trials to reduce the time and cost of drug development. The collaboration includes the availability of HCL’s Faster Intelligent Trials (FIT) Solution using Oracle Health Sciences Mobile Health (mHealth) Connector Cloud Service (Oracle mHealth Cloud).
Infosys announced a strategic partnership with University of Illinois Urbana-Champaign (UIUC) to develop new technologies and systems in precision medicine.
Medical device industry news
Hong Kong becomes world’s second largest funding hub for biotech.
Ransomware hits hundreds of dentists offices in US.
Amazon launches Amazon Care, a virtual and in-person healthcare offering for employees
Medical device resources: consultant/ analyst updates
Read Previous Articles of Automotive EIIR Trends